Free Trial

CollPlant Biotechnologies (CLGN) SEC Filings & 10K Form

CollPlant Biotechnologies logo
$3.41 -0.26 (-7.08%)
(As of 12/20/2024 05:16 PM ET)

Recent CollPlant Biotechnologies SEC Filings

DateFilerForm TypeView
11/27/2024
6:17 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
6:00 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
3:15 PM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
6:11 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
7:34 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
6:09 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
6:04 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
3:34 PM
CollPlant Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2024
6:07 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
6:07 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
6:00 AM
CollPlant Biotechnologies (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/15/2024
7:19 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
6:09 AM
CollPlant Biotechnologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CLGN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners